Holistic, Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 4502 N Federal Hwy Apt 215b, Lighthouse Point, FL 33064 Phone: 954-663-7657 |
Renew Psychiatric Care, Llc Clinical Neuropsychologist Medicare: Not Enrolled in Medicare Practice Location: 3170 N Federal Hwy Ste 206b, Lighthouse Point, FL 33064 Phone: 954-522-5100 |
Pediatric Neurology Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Not Enrolled in Medicare Practice Location: 4510 N Federal Hwy, Lighthouse Point, FL 33064 Phone: 954-781-2211 Fax: 954-781-6715 |
Jill A. Selbach, Ph.d., P.a. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3650 N Federal Hwy, 215, Lighthouse Point, FL 33064 Phone: 954-618-8412 Fax: 954-782-8389 |
Prevailing Truth Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3640 N Federal Hwy, Ste B3 #128, Lighthouse Point, FL 33064 Phone: 954-599-8946 |
Waden E Emery Iii M D P A Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 5340 N Federal Hwy, Suite 205, Lighthouse Point, FL 33064 Phone: 954-771-8300 Fax: 954-771-4002 |
Child's View, P.a. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3170 N Federal Hwy, #211-i, Lighthouse Point, FL 33064 Phone: 954-830-8588 |
News Archive
Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.
Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ .
Despite advances in treatment regimens and the best efforts of nurses and doctors, about 70% of all people with severe burns die from related infections. But a revolutionary new wound dressing developed at Tel Aviv University could cut that number dramatically.
Salix Pharmaceuticals, Ltd. today announced that Salix and Norgine B. V. have entered into an agreement with Novel Laboratories, Inc. to settle patent litigation currently pending in the U.S. District Court for the District of New Jersey (Civil Action No. 3:08-02311 (FLW)(TJB)) regarding Novel's proposed generic version of MOVIPREP.
Researchers at Queen Mary University of London and University College London have shown that using stem cells derived from patients could help find new treatments for a group of congenital muscular dystrophies.
› Verified 4 days ago